There were 863 press releases posted in the last 24 hours and 443,219 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Impel NeuroPharma Announces U.S. Food & Drug Administration Acceptance of New Drug Application for INP104 for the Acute Treatment of Migraine

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image